

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.29073641 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.54872519 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.87705163 |
| 4 | myofibril assembly (GO:0030239) | 7.60286194 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 7.17553856 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.10585269 |
| 7 | actin-myosin filament sliding (GO:0033275) | 6.61074459 |
| 8 | muscle filament sliding (GO:0030049) | 6.61074459 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.57428783 |
| 10 | cardiac muscle contraction (GO:0060048) | 6.57142071 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.48318708 |
| 12 | cardiac muscle cell development (GO:0055013) | 6.40014462 |
| 13 | plasma membrane repair (GO:0001778) | 6.28872826 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.15747575 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.09734425 |
| 16 | cardiac cell development (GO:0055006) | 5.97598096 |
| 17 | adult heart development (GO:0007512) | 5.94013273 |
| 18 | regulation of actin filament-based movement (GO:1903115) | 5.85034934 |
| 19 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.80961083 |
| 20 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.77609073 |
| 21 | skeletal muscle contraction (GO:0003009) | 5.77285539 |
| 22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.77130985 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.74377531 |
| 24 | ATP synthesis coupled proton transport (GO:0015986) | 5.71735732 |
| 25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.71735732 |
| 26 | actomyosin structure organization (GO:0031032) | 5.71397749 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.68065879 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.59335401 |
| 29 | regulation of relaxation of muscle (GO:1901077) | 5.56068961 |
| 30 | actin-mediated cell contraction (GO:0070252) | 5.40141554 |
| 31 | cardiac muscle hypertrophy (GO:0003300) | 5.37739221 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.34148156 |
| 33 | carnitine shuttle (GO:0006853) | 5.31934044 |
| 34 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.29976079 |
| 35 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.24016971 |
| 36 | regulation of skeletal muscle contraction (GO:0014819) | 5.23969508 |
| 37 | heart trabecula formation (GO:0060347) | 5.17659680 |
| 38 | muscle tissue morphogenesis (GO:0060415) | 5.12651691 |
| 39 | respiratory electron transport chain (GO:0022904) | 5.12226114 |
| 40 | heart contraction (GO:0060047) | 5.11949836 |
| 41 | heart process (GO:0003015) | 5.11949836 |
| 42 | regulation of sarcomere organization (GO:0060297) | 5.10057809 |
| 43 | striated muscle hypertrophy (GO:0014897) | 5.08466558 |
| 44 | striated muscle contraction (GO:0006941) | 5.04096999 |
| 45 | electron transport chain (GO:0022900) | 4.97456294 |
| 46 | response to inactivity (GO:0014854) | 4.96778021 |
| 47 | regulation of cofactor metabolic process (GO:0051193) | 4.85542906 |
| 48 | regulation of coenzyme metabolic process (GO:0051196) | 4.85542906 |
| 49 | NADH metabolic process (GO:0006734) | 4.80713113 |
| 50 | regulation of striated muscle contraction (GO:0006942) | 4.76638305 |
| 51 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.76139547 |
| 52 | regulation of the force of heart contraction (GO:0002026) | 4.75457151 |
| 53 | oxidative phosphorylation (GO:0006119) | 4.67134322 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.62114647 |
| 55 | regulation of cell communication by electrical coupling (GO:0010649) | 4.60821754 |
| 56 | cell communication involved in cardiac conduction (GO:0086065) | 4.57213371 |
| 57 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.55660296 |
| 58 | fatty acid transmembrane transport (GO:1902001) | 4.54419433 |
| 59 | regulation of membrane repolarization (GO:0060306) | 4.52620747 |
| 60 | muscle hypertrophy (GO:0014896) | 4.46558631 |
| 61 | regulation of cardioblast differentiation (GO:0051890) | 4.35437824 |
| 62 | response to muscle activity (GO:0014850) | 4.20656682 |
| 63 | muscle system process (GO:0003012) | 4.20476115 |
| 64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.17918746 |
| 65 | carnitine transmembrane transport (GO:1902603) | 4.16308038 |
| 66 | regulation of ATP catabolic process (GO:1903289) | 4.11911934 |
| 67 | regulation of ATPase activity (GO:0043462) | 4.11911934 |
| 68 | cardiac chamber formation (GO:0003207) | 4.04555442 |
| 69 | regulation of cardiac muscle contraction (GO:0055117) | 4.03439780 |
| 70 | negative regulation of protein localization to cell surface (GO:2000009) | 4.03288978 |
| 71 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.02820321 |
| 72 | regulation of heart rate (GO:0002027) | 3.99501988 |
| 73 | negative regulation of potassium ion transport (GO:0043267) | 3.99163107 |
| 74 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.98993491 |
| 75 | muscle hypertrophy in response to stress (GO:0003299) | 3.98993491 |
| 76 | cardiac muscle adaptation (GO:0014887) | 3.98993491 |
| 77 | actin filament-based movement (GO:0030048) | 3.98012135 |
| 78 | cardiac muscle cell action potential (GO:0086001) | 3.96064478 |
| 79 | cell communication by electrical coupling (GO:0010644) | 3.95697622 |
| 80 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.93468354 |
| 81 | striated muscle adaptation (GO:0014888) | 3.93188311 |
| 82 | ventricular cardiac muscle cell development (GO:0055015) | 3.91362694 |
| 83 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.89547399 |
| 84 | detection of calcium ion (GO:0005513) | 3.88726775 |
| 85 | cardiac ventricle formation (GO:0003211) | 3.88719454 |
| 86 | regulation of sulfur metabolic process (GO:0042762) | 3.88665603 |
| 87 | creatine metabolic process (GO:0006600) | 3.87871195 |
| 88 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.85865901 |
| 89 | regulation of sequestering of triglyceride (GO:0010889) | 3.85785833 |
| 90 | oxygen transport (GO:0015671) | 3.85695958 |
| 91 | carnitine transport (GO:0015879) | 3.84580450 |
| 92 | amino-acid betaine transport (GO:0015838) | 3.84580450 |
| 93 | 2-oxoglutarate metabolic process (GO:0006103) | 3.81834053 |
| 94 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.73321594 |
| 95 | regulation of heart contraction (GO:0008016) | 3.69422882 |
| 96 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.69123061 |
| 97 | ATP biosynthetic process (GO:0006754) | 3.64781484 |
| 98 | regulation of muscle contraction (GO:0006937) | 3.60153238 |
| 99 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.57526154 |
| 100 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.57526154 |
| 101 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.56124136 |
| 102 | response to epinephrine (GO:0071871) | 3.54039654 |
| 103 | striated muscle cell development (GO:0055002) | 3.53878059 |
| 104 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.52107360 |
| 105 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.51389588 |
| 106 | cardiac conduction (GO:0061337) | 3.43766395 |
| 107 | relaxation of cardiac muscle (GO:0055119) | 3.42806054 |
| 108 | succinate metabolic process (GO:0006105) | 3.41792064 |
| 109 | positive regulation of heart rate (GO:0010460) | 3.41463974 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 3.41185484 |
| 111 | regulation of muscle system process (GO:0090257) | 3.40907360 |
| 112 | positive regulation of cation channel activity (GO:2001259) | 3.40733636 |
| 113 | cellular response to epinephrine stimulus (GO:0071872) | 3.39885135 |
| 114 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.37523848 |
| 115 | positive regulation of heart contraction (GO:0045823) | 3.34309005 |
| 116 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.30540217 |
| 117 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.30540217 |
| 118 | muscle contraction (GO:0006936) | 3.29910578 |
| 119 | muscle fiber development (GO:0048747) | 3.27500714 |
| 120 | muscle adaptation (GO:0043500) | 3.26200832 |
| 121 | muscle cell cellular homeostasis (GO:0046716) | 3.22799423 |
| 122 | regulation of cation channel activity (GO:2001257) | 3.14798027 |
| 123 | response to caffeine (GO:0031000) | 3.14689489 |
| 124 | mitochondrial genome maintenance (GO:0000002) | 3.10978828 |
| 125 | skeletal muscle adaptation (GO:0043501) | 3.05268491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.38982743 |
| 2 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.46070036 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.46393804 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.15481911 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.06900720 |
| 6 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.78382447 |
| 7 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.78382447 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.68404293 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.88240642 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79263633 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.70713184 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.47661850 |
| 13 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.45776642 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.36491025 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21726005 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.07036064 |
| 17 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.06327503 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94186148 |
| 19 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.88740178 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87252634 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.76625953 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69928147 |
| 23 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.60740537 |
| 24 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59610493 |
| 25 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.57613462 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55293764 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53698130 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50878530 |
| 29 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.50589324 |
| 30 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.50154342 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.47403962 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47058408 |
| 33 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42872932 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38620126 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37651593 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36507961 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35294804 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32362827 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29529797 |
| 40 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29134267 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.29101310 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28734475 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.28202694 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28187435 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27364639 |
| 46 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.26003847 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25525402 |
| 48 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24569378 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22630858 |
| 50 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21341084 |
| 51 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.20836444 |
| 52 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.20175320 |
| 53 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18821533 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.16152484 |
| 55 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.16152484 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16044678 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13602983 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12516042 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12226233 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09299099 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06166021 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05694709 |
| 63 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05500700 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.04805659 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04054758 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03483976 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03289341 |
| 68 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00729155 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00625504 |
| 70 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.99409662 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99209512 |
| 72 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99120151 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99108207 |
| 74 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.97781667 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97375976 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96779036 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96536479 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95682280 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95187261 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93631444 |
| 81 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93142454 |
| 82 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93088213 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92150317 |
| 84 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91750404 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91160704 |
| 86 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89660571 |
| 87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89186134 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88820943 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88330279 |
| 90 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88206631 |
| 91 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88025033 |
| 92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86347912 |
| 93 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86236974 |
| 94 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86151771 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85840728 |
| 96 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.85056317 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84856134 |
| 98 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.84274189 |
| 99 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84130741 |
| 100 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.83137368 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82851472 |
| 102 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82800861 |
| 103 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82037524 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81794496 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80998928 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80998928 |
| 107 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80685586 |
| 108 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80549412 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80432831 |
| 110 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80199264 |
| 111 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.80027263 |
| 112 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.79645837 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79445759 |
| 114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79428153 |
| 115 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78765824 |
| 116 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.78263756 |
| 117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78181940 |
| 118 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78124267 |
| 119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78031526 |
| 120 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.77951652 |
| 121 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.77895837 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77320325 |
| 123 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.77272212 |
| 124 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77052110 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76903374 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76842804 |
| 127 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.76653287 |
| 128 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76324425 |
| 129 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.75880060 |
| 130 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75769616 |
| 131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75638264 |
| 132 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.75124690 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.74473095 |
| 134 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74068926 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.73801071 |
| 136 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.73545981 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73464936 |
| 138 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73455672 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72599221 |
| 140 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.72457593 |
| 141 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.71487088 |
| 142 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.70318026 |
| 143 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70307416 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69788253 |
| 145 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.69670277 |
| 146 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.69396485 |
| 147 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.67969923 |
| 148 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67964153 |
| 149 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67663510 |
| 150 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.67389434 |
| 151 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.66495557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.48563123 |
| 2 | MP0003646_muscle_fatigue | 5.98393721 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.95977910 |
| 4 | MP0000751_myopathy | 5.03377457 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.86236645 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.24491312 |
| 7 | MP0005330_cardiomyopathy | 3.95026300 |
| 8 | MP0000749_muscle_degeneration | 3.61230323 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.13632755 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.98221702 |
| 11 | MP0003137_abnormal_impulse_conducting | 2.92009579 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.87168365 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.74363411 |
| 14 | * MP0005385_cardiovascular_system_phenoty | 2.59283331 |
| 15 | * MP0001544_abnormal_cardiovascular_syste | 2.59283331 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.58888925 |
| 17 | MP0006138_congestive_heart_failure | 2.56036612 |
| 18 | MP0010630_abnormal_cardiac_muscle | 2.53530363 |
| 19 | MP0004484_altered_response_of | 2.50231325 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.37669926 |
| 21 | MP0003828_pulmonary_edema | 2.32869408 |
| 22 | MP0002269_muscular_atrophy | 2.30650256 |
| 23 | MP0004085_abnormal_heartbeat | 2.14402347 |
| 24 | MP0003221_abnormal_cardiomyocyte_apopto | 1.95216486 |
| 25 | * MP0004130_abnormal_muscle_cell | 1.93597064 |
| 26 | MP0005369_muscle_phenotype | 1.92571137 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.89681799 |
| 28 | MP0000747_muscle_weakness | 1.85148253 |
| 29 | MP0000759_abnormal_skeletal_muscle | 1.82874791 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.82675739 |
| 31 | MP0004233_abnormal_muscle_weight | 1.71150999 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.64087397 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.62145688 |
| 34 | MP0004510_myositis | 1.55115446 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.52530460 |
| 36 | MP0005670_abnormal_white_adipose | 1.48141109 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.46722683 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.29465960 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.28010380 |
| 40 | MP0001881_abnormal_mammary_gland | 1.10893959 |
| 41 | MP0000343_altered_response_to | 1.09630920 |
| 42 | MP0005165_increased_susceptibility_to | 1.07837041 |
| 43 | * MP0000266_abnormal_heart_morphology | 1.06660083 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.00928950 |
| 45 | MP0002234_abnormal_pharynx_morphology | 0.99879173 |
| 46 | MP0004270_analgesia | 0.98958960 |
| 47 | MP0005375_adipose_tissue_phenotype | 0.98302119 |
| 48 | MP0005266_abnormal_metabolism | 0.92928849 |
| 49 | MP0003279_aneurysm | 0.90032562 |
| 50 | MP0010368_abnormal_lymphatic_system | 0.87364729 |
| 51 | MP0005623_abnormal_meninges_morphology | 0.85234188 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 0.84344308 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.77646541 |
| 54 | MP0001661_extended_life_span | 0.76997359 |
| 55 | MP0000230_abnormal_systemic_arterial | 0.76535589 |
| 56 | MP0002108_abnormal_muscle_morphology | 0.74000904 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.70809666 |
| 58 | MP0002128_abnormal_blood_circulation | 0.69820806 |
| 59 | MP0002909_abnormal_adrenal_gland | 0.68633981 |
| 60 | MP0009840_abnormal_foam_cell | 0.67256951 |
| 61 | MP0008569_lethality_at_weaning | 0.66030705 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.63672257 |
| 63 | MP0004043_abnormal_pH_regulation | 0.60724335 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.57896047 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 0.57004524 |
| 66 | MP0008004_abnormal_stomach_pH | 0.56075769 |
| 67 | MP0004272_abnormal_basement_membrane | 0.55923260 |
| 68 | MP0005187_abnormal_penis_morphology | 0.55606386 |
| 69 | MP0003984_embryonic_growth_retardation | 0.55279336 |
| 70 | MP0001727_abnormal_embryo_implantation | 0.54303220 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 0.54042133 |
| 72 | MP0003195_calcinosis | 0.47982131 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 0.47133108 |
| 74 | MP0000767_abnormal_smooth_muscle | 0.46201675 |
| 75 | MP0002971_abnormal_brown_adipose | 0.44692045 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43389894 |
| 77 | MP0003045_fibrosis | 0.43359427 |
| 78 | MP0001984_abnormal_olfaction | 0.43061981 |
| 79 | MP0005451_abnormal_body_composition | 0.42708102 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.42017034 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 0.41884131 |
| 82 | MP0005535_abnormal_body_temperature | 0.41843196 |
| 83 | MP0004147_increased_porphyrin_level | 0.41693726 |
| 84 | * MP0002078_abnormal_glucose_homeostasis | 0.40522993 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.40504522 |
| 86 | MP0003329_amyloid_beta_deposits | 0.39871239 |
| 87 | MP0008874_decreased_physiological_sensi | 0.39212027 |
| 88 | MP0002925_abnormal_cardiovascular_devel | 0.39201249 |
| 89 | MP0005380_embryogenesis_phenotype | 0.37399398 |
| 90 | MP0001672_abnormal_embryogenesis/_devel | 0.37399398 |
| 91 | MP0003879_abnormal_hair_cell | 0.36835627 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.36288433 |
| 93 | MP0002822_catalepsy | 0.36138600 |
| 94 | MP0003941_abnormal_skin_development | 0.33689924 |
| 95 | MP0004859_abnormal_synaptic_plasticity | 0.33550208 |
| 96 | MP0005332_abnormal_amino_acid | 0.33024759 |
| 97 | MP0000358_abnormal_cell_content/ | 0.33011203 |
| 98 | MP0000733_abnormal_muscle_development | 0.32867950 |
| 99 | MP0001784_abnormal_fluid_regulation | 0.32211426 |
| 100 | MP0001958_emphysema | 0.30784747 |
| 101 | MP0003948_abnormal_gas_homeostasis | 0.30296038 |
| 102 | MP0002272_abnormal_nervous_system | 0.28947876 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.28770325 |
| 104 | MP0001614_abnormal_blood_vessel | 0.28257542 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.28070691 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.27556308 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.27485939 |
| 108 | MP0005452_abnormal_adipose_tissue | 0.27481935 |
| 109 | MP0003878_abnormal_ear_physiology | 0.26812797 |
| 110 | MP0005377_hearing/vestibular/ear_phenot | 0.26812797 |
| 111 | * MP0005386_behavior/neurological_phenoty | 0.26348987 |
| 112 | * MP0004924_abnormal_behavior | 0.26348987 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.26277715 |
| 114 | MP0002254_reproductive_system_inflammat | 0.25563815 |
| 115 | MP0002064_seizures | 0.25131867 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.25070976 |
| 117 | MP0008438_abnormal_cutaneous_collagen | 0.24505663 |
| 118 | MP0001756_abnormal_urination | 0.24287696 |
| 119 | MP0009745_abnormal_behavioral_response | 0.24206990 |
| 120 | MP0002066_abnormal_motor_capabilities/c | 0.24206024 |
| 121 | MP0009115_abnormal_fat_cell | 0.23933573 |
| 122 | MP0002090_abnormal_vision | 0.23096768 |
| 123 | MP0005334_abnormal_fat_pad | 0.22607779 |
| 124 | * MP0002118_abnormal_lipid_homeostasis | 0.22528537 |
| 125 | MP0005083_abnormal_biliary_tract | 0.22394409 |
| 126 | MP0005275_abnormal_skin_tensile | 0.22103637 |
| 127 | MP0008961_abnormal_basal_metabolism | 0.21519000 |
| 128 | MP0001529_abnormal_vocalization | 0.21338771 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.20373208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.14371547 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.10100331 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 7.09380723 |
| 4 | Ventricular tachycardia (HP:0004756) | 7.00692910 |
| 5 | Nemaline bodies (HP:0003798) | 6.85393089 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 6.14771281 |
| 7 | Atrial fibrillation (HP:0005110) | 5.91359121 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.80829531 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.58569383 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 5.55272499 |
| 11 | Supraventricular tachycardia (HP:0004755) | 5.38170698 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 5.36371515 |
| 13 | Lipoatrophy (HP:0100578) | 5.32645011 |
| 14 | Exercise-induced myalgia (HP:0003738) | 5.29809644 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 5.28633888 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 5.04793758 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 4.91849474 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.85375515 |
| 19 | Subaortic stenosis (HP:0001682) | 4.85375515 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 4.74776620 |
| 21 | Syncope (HP:0001279) | 4.71616552 |
| 22 | Palpitations (HP:0001962) | 4.59125042 |
| 23 | Bundle branch block (HP:0011710) | 4.53715900 |
| 24 | Myoglobinuria (HP:0002913) | 4.46084751 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 4.42634450 |
| 26 | Prolonged QT interval (HP:0001657) | 4.20804701 |
| 27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.18719053 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 4.07166140 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.92747770 |
| 30 | Ventricular arrhythmia (HP:0004308) | 3.91234377 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 3.81798322 |
| 32 | Increased connective tissue (HP:0009025) | 3.80788499 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.75768676 |
| 34 | Heart block (HP:0012722) | 3.73184348 |
| 35 | Ventricular fibrillation (HP:0001663) | 3.63566772 |
| 36 | Atrioventricular block (HP:0001678) | 3.62262267 |
| 37 | Hepatic necrosis (HP:0002605) | 3.55039154 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 3.52332343 |
| 39 | Rhabdomyolysis (HP:0003201) | 3.45935223 |
| 40 | Difficulty running (HP:0009046) | 3.43550765 |
| 41 | Myotonia (HP:0002486) | 3.38443909 |
| 42 | Acute encephalopathy (HP:0006846) | 3.24732146 |
| 43 | Hepatocellular necrosis (HP:0001404) | 3.18857893 |
| 44 | Myopathic facies (HP:0002058) | 3.17509465 |
| 45 | Mitochondrial inheritance (HP:0001427) | 3.14144745 |
| 46 | Progressive macrocephaly (HP:0004481) | 3.12900016 |
| 47 | Difficulty climbing stairs (HP:0003551) | 3.11933302 |
| 48 | Distal arthrogryposis (HP:0005684) | 3.08234559 |
| 49 | Abnormal EKG (HP:0003115) | 3.05253982 |
| 50 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.96346167 |
| 51 | Increased CSF lactate (HP:0002490) | 2.93087637 |
| 52 | Cerebral edema (HP:0002181) | 2.90423155 |
| 53 | Left ventricular hypertrophy (HP:0001712) | 2.89587301 |
| 54 | Generalized muscle weakness (HP:0003324) | 2.85679900 |
| 55 | Round ear (HP:0100830) | 2.81940501 |
| 56 | Palmoplantar keratoderma (HP:0000982) | 2.74861875 |
| 57 | Ketoacidosis (HP:0001993) | 2.74385629 |
| 58 | Testicular atrophy (HP:0000029) | 2.72899948 |
| 59 | Increased muscle lipid content (HP:0009058) | 2.68080384 |
| 60 | Frequent falls (HP:0002359) | 2.67766394 |
| 61 | Hypoglycemic coma (HP:0001325) | 2.63220307 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.60023561 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.59721206 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59721206 |
| 65 | Lower limb amyotrophy (HP:0007210) | 2.59450065 |
| 66 | Respiratory failure (HP:0002878) | 2.56639305 |
| 67 | Ragged-red muscle fibers (HP:0003200) | 2.52631382 |
| 68 | Ulnar deviation of the wrist (HP:0003049) | 2.51389968 |
| 69 | Lactic acidosis (HP:0003128) | 2.50507965 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48535412 |
| 71 | Exercise intolerance (HP:0003546) | 2.47486106 |
| 72 | Areflexia of lower limbs (HP:0002522) | 2.43025364 |
| 73 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42116053 |
| 74 | Conjunctival hamartoma (HP:0100780) | 2.39102679 |
| 75 | Neck muscle weakness (HP:0000467) | 2.38718045 |
| 76 | Gowers sign (HP:0003391) | 2.38631742 |
| 77 | Scapular winging (HP:0003691) | 2.37787863 |
| 78 | Bulbar palsy (HP:0001283) | 2.36784188 |
| 79 | Muscle stiffness (HP:0003552) | 2.32711912 |
| 80 | Limb-girdle muscle atrophy (HP:0003797) | 2.32596111 |
| 81 | Pheochromocytoma (HP:0002666) | 2.31752646 |
| 82 | Athetosis (HP:0002305) | 2.30243557 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26858096 |
| 84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16307005 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 2.16307005 |
| 86 | Hyperalaninemia (HP:0003348) | 2.16307005 |
| 87 | Progressive muscle weakness (HP:0003323) | 2.12748632 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08385583 |
| 89 | Abnormality of the foot musculature (HP:0001436) | 2.07915154 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.07369897 |
| 91 | Double outlet right ventricle (HP:0001719) | 2.06603800 |
| 92 | Congenital malformation of the right heart (HP:0011723) | 2.06603800 |
| 93 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03955287 |
| 94 | Dysmetric saccades (HP:0000641) | 2.01923133 |
| 95 | Weak cry (HP:0001612) | 2.01659598 |
| 96 | Calcaneovalgus deformity (HP:0001848) | 2.00988941 |
| 97 | Ketosis (HP:0001946) | 1.97106066 |
| 98 | Sudden cardiac death (HP:0001645) | 1.95756194 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.94897352 |
| 100 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94798298 |
| 101 | Rimmed vacuoles (HP:0003805) | 1.94441890 |
| 102 | Esophageal neoplasm (HP:0100751) | 1.93846376 |
| 103 | Neoplasm of head and neck (HP:0012288) | 1.93846376 |
| 104 | Congestive heart failure (HP:0001635) | 1.93832336 |
| 105 | Hamartoma of the eye (HP:0010568) | 1.93275076 |
| 106 | Steppage gait (HP:0003376) | 1.93016115 |
| 107 | Proximal amyotrophy (HP:0007126) | 1.92131381 |
| 108 | Distal lower limb amyotrophy (HP:0008944) | 1.90890449 |
| 109 | Neoplasm of the adrenal gland (HP:0100631) | 1.90045352 |
| 110 | Abnormality of glycolysis (HP:0004366) | 1.89386401 |
| 111 | Increased serum pyruvate (HP:0003542) | 1.89386401 |
| 112 | Hypoplastic heart (HP:0001961) | 1.88848618 |
| 113 | EMG: neuropathic changes (HP:0003445) | 1.88485186 |
| 114 | Muscular dystrophy (HP:0003560) | 1.88098902 |
| 115 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87252154 |
| 116 | Absent phalangeal crease (HP:0006109) | 1.84143852 |
| 117 | Tinnitus (HP:0000360) | 1.83934670 |
| 118 | Large for gestational age (HP:0001520) | 1.83834551 |
| 119 | Type 1 muscle fiber predominance (HP:0003803) | 1.83205719 |
| 120 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81306976 |
| 121 | Hypoplastic left heart (HP:0004383) | 1.81221852 |
| 122 | Increased serum lactate (HP:0002151) | 1.80108657 |
| 123 | Waddling gait (HP:0002515) | 1.78811415 |
| 124 | Hyperglycinuria (HP:0003108) | 1.78605626 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78224175 |
| 126 | Generalized aminoaciduria (HP:0002909) | 1.77269323 |
| 127 | Deformed tarsal bones (HP:0008119) | 1.74961870 |
| 128 | Hip contracture (HP:0003273) | 1.72855575 |
| 129 | Malignant hyperthermia (HP:0002047) | 1.66987216 |
| 130 | Abnormality of the neuromuscular junction (HP:0003398) | 1.65517364 |
| 131 | Fatigable weakness (HP:0003473) | 1.65517364 |
| 132 | Abnormality of the tricuspid valve (HP:0001702) | 1.63547470 |
| 133 | Aplasia of the musculature (HP:0100854) | 1.62404383 |
| 134 | Fetal akinesia sequence (HP:0001989) | 1.61577014 |
| 135 | Spinal rigidity (HP:0003306) | 1.49671485 |
| 136 | Abnormal finger flexion creases (HP:0006143) | 1.43846310 |
| 137 | Limb-girdle muscle weakness (HP:0003325) | 1.43710279 |
| 138 | Skin nodule (HP:0200036) | 1.43371072 |
| 139 | Bradycardia (HP:0001662) | 1.41849873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.67836669 |
| 2 | MYLK | 4.34995820 |
| 3 | LMTK2 | 4.10194283 |
| 4 | PDK3 | 4.08256209 |
| 5 | PDK4 | 4.08256209 |
| 6 | PHKG2 | 3.83826188 |
| 7 | PHKG1 | 3.83826188 |
| 8 | OBSCN | 3.43412354 |
| 9 | NEK1 | 2.96431365 |
| 10 | PKN2 | 2.75979176 |
| 11 | DMPK | 2.66777177 |
| 12 | BCKDK | 2.58970311 |
| 13 | PDK2 | 2.56390992 |
| 14 | TRIB3 | 2.43858433 |
| 15 | MUSK | 2.17891763 |
| 16 | PINK1 | 2.16075699 |
| 17 | PIK3CA | 2.13002220 |
| 18 | TIE1 | 1.96257528 |
| 19 | PIK3CG | 1.86223575 |
| 20 | LIMK1 | 1.79230194 |
| 21 | STK24 | 1.71818074 |
| 22 | MARK1 | 1.71365028 |
| 23 | EPHA2 | 1.66510510 |
| 24 | PAK3 | 1.54650051 |
| 25 | GRK7 | 1.45310375 |
| 26 | CAMK2D | 1.45070055 |
| 27 | ILK | 1.29014350 |
| 28 | STK38L | 1.28245991 |
| 29 | CDC42BPA | 1.27855153 |
| 30 | PRKD1 | 1.24744245 |
| 31 | DAPK3 | 1.21554231 |
| 32 | NME1 | 1.17379578 |
| 33 | MAPKAPK3 | 1.10354610 |
| 34 | ROCK1 | 1.01580402 |
| 35 | MAPK12 | 0.94492080 |
| 36 | ZAK | 0.94306351 |
| 37 | STK4 | 0.93882747 |
| 38 | STK38 | 0.92192490 |
| 39 | WNK4 | 0.91554781 |
| 40 | MAP3K6 | 0.91443222 |
| 41 | MAP3K5 | 0.91156559 |
| 42 | PRKAA1 | 0.83812940 |
| 43 | NME2 | 0.78034236 |
| 44 | PKN1 | 0.74098378 |
| 45 | RIPK1 | 0.72779845 |
| 46 | ROCK2 | 0.71682272 |
| 47 | CAMK2A | 0.67689796 |
| 48 | PRKAA2 | 0.66466803 |
| 49 | CAMK1 | 0.65299800 |
| 50 | MAPK4 | 0.65088496 |
| 51 | RPS6KC1 | 0.64829777 |
| 52 | RPS6KL1 | 0.64829777 |
| 53 | MAP3K7 | 0.64223921 |
| 54 | KDR | 0.62171704 |
| 55 | EPHA3 | 0.62027946 |
| 56 | MAP3K3 | 0.61589421 |
| 57 | CAMK4 | 0.61267617 |
| 58 | PRKCE | 0.59826947 |
| 59 | RPS6KB2 | 0.58115330 |
| 60 | MOS | 0.58023615 |
| 61 | PDGFRA | 0.55373964 |
| 62 | TESK1 | 0.54364141 |
| 63 | MAPK7 | 0.53835829 |
| 64 | PTK2B | 0.53707460 |
| 65 | RPS6KA6 | 0.52101661 |
| 66 | PRKACB | 0.50520125 |
| 67 | KSR2 | 0.49977361 |
| 68 | LATS2 | 0.49533031 |
| 69 | PRKG1 | 0.47607746 |
| 70 | CAMK2G | 0.47234404 |
| 71 | FLT3 | 0.46059022 |
| 72 | MAP2K3 | 0.45683791 |
| 73 | ARAF | 0.45095319 |
| 74 | MAP2K6 | 0.44192848 |
| 75 | TRPM7 | 0.43472072 |
| 76 | PDPK1 | 0.41491149 |
| 77 | PRKACA | 0.41460107 |
| 78 | FER | 0.39098303 |
| 79 | PNCK | 0.38614964 |
| 80 | DAPK2 | 0.38054063 |
| 81 | CCNB1 | 0.37860162 |
| 82 | ICK | 0.37524523 |
| 83 | PRKACG | 0.37415095 |
| 84 | INSRR | 0.35908006 |
| 85 | ZAP70 | 0.35393463 |
| 86 | WNK1 | 0.33995894 |
| 87 | EPHB1 | 0.33784525 |
| 88 | CAMK1D | 0.33297532 |
| 89 | UHMK1 | 0.32632622 |
| 90 | EEF2K | 0.30956467 |
| 91 | AKT2 | 0.30894160 |
| 92 | MAP3K4 | 0.30545960 |
| 93 | EPHA4 | 0.29628811 |
| 94 | PDK1 | 0.26948276 |
| 95 | CDK5 | 0.26944547 |
| 96 | SGK2 | 0.25944323 |
| 97 | MARK2 | 0.25807000 |
| 98 | TGFBR2 | 0.24356983 |
| 99 | CAMK2B | 0.24051173 |
| 100 | DYRK1B | 0.23787895 |
| 101 | MAPK10 | 0.21956950 |
| 102 | PRPF4B | 0.21913773 |
| 103 | RPS6KA1 | 0.21768802 |
| 104 | MTOR | 0.21686595 |
| 105 | TAOK2 | 0.21183254 |
| 106 | ABL2 | 0.18823989 |
| 107 | SGK494 | 0.18818160 |
| 108 | SGK223 | 0.18818160 |
| 109 | DDR2 | 0.18736295 |
| 110 | PRKD3 | 0.17102068 |
| 111 | MAP3K1 | 0.16942874 |
| 112 | CAMK1G | 0.16815643 |
| 113 | MAP3K11 | 0.16588443 |
| 114 | STK39 | 0.16552306 |
| 115 | SIK1 | 0.15457030 |
| 116 | STK11 | 0.14602496 |
| 117 | TAOK1 | 0.14280164 |
| 118 | MAP3K12 | 0.14272905 |
| 119 | EPHB2 | 0.12888628 |
| 120 | PRKG2 | 0.12778816 |
| 121 | NEK9 | 0.12595551 |
| 122 | ERBB3 | 0.12344941 |
| 123 | RPS6KA2 | 0.12040149 |
| 124 | RPS6KA3 | 0.10795789 |
| 125 | SGK3 | 0.09504724 |
| 126 | PTK6 | 0.09366847 |
| 127 | MAP2K1 | 0.09091908 |
| 128 | RET | 0.08706732 |
| 129 | MAPKAPK2 | 0.08558535 |
| 130 | SGK1 | 0.08498462 |
| 131 | GRK5 | 0.07990280 |
| 132 | MAP2K4 | 0.07976144 |
| 133 | PAK6 | 0.07643302 |
| 134 | PRKCD | 0.07373525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.09788077 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.50805390 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.40211066 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.07965226 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.93550641 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.38208211 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.29966755 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21008956 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15989487 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.86026940 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.62993595 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.56991835 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.53228343 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46633212 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11498041 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.07734180 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03075890 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.92102881 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63393393 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56204745 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52333497 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31919756 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21875265 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21824973 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16347596 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04815913 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00084837 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92542418 |
| 29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86541853 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86437971 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79194448 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 0.78585241 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78144720 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77437285 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76247231 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75777042 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.70366491 |
| 38 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70181526 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68518164 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65031537 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64728572 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64429179 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64256455 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63250322 |
| 45 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60630651 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60405357 |
| 47 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59069034 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58083770 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56983864 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55040218 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51704834 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49419818 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.48874405 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48726804 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 0.48441277 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46731595 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46705671 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46213602 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 0.45005953 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42356146 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42199901 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40473160 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.39604156 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37724132 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35953616 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35794226 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.34923092 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33467278 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33392873 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.31431990 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31048531 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29726516 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27336793 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26911373 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26749958 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26050547 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.25835906 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25758711 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.25717308 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.25319633 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24795625 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24490984 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.21756906 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21726993 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20875002 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19856748 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19646612 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19613566 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.18760351 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.18258147 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.18075405 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.17175824 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16539546 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.16251334 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.15430573 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15211486 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.14859983 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14744982 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13863515 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13842062 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13288161 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.12859470 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11771566 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.11310565 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.10416926 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08940630 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08589805 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08097687 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06530951 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.05446781 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.03240931 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00532508 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0360075 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0301630 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | -0.0292311 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0292156 |
| 117 | Ribosome_Homo sapiens_hsa03010 | -0.0256168 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0158650 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0139634 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0032384 |

